Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung

作者: Luisella Righi , Simona Vatrano , Federica Di Nicolantonio , Federica Massa , Giulio Rossi

DOI: 10.1016/J.JTHO.2016.01.004

关键词:

摘要: Abstract Introduction Mucin-rich lung adenocarcinomas (ADCs), namely mucinous and colloid ADCs, are classified as ADC variants according to the World Health Organization 2015 classification. A correlation between morphological patterns mutational status of these rare entities is not well established. Methods We investigated profile mucin-rich ADCs in with histopathological features goal identifying biological tumor characteristics potential prognostic therapeutic interest. series 54 surgically resected primary samples were retrospectively analyzed for clinicopathological by targeted next-generation sequencing. Results Fifty cases invasive (32 pure 18 mixed) four colloid-predominant ADCs. Invasive a pattern associated lower risk vascular invasion ( p  = 0.01), absence signet ring cells 0.03), negative nodal 0.006), early clinical stage 0.02). The most prevalent mutations involved Kirsten rat sarcoma viral oncogene homolog gene KRAS ) protein p53 TP53 ). Most clustered mitogen-activated protein/protein kinase B pathway p53/DNA repair pathway. few uncommon epidermal growth factor receptor EGFR found. higher number favorable outcome was seen Conclusions Our data showed that have peculiar pathological molecular might suggest need differentially tailored approach compared conventional ADC.

参考文章(48)
William D. Travis, WHO classification of tumours of the lung, pleura, thymus and heart International Agency for Research on Cancer. ,(2015)
Hyo Sup Shim, Mari- Kenudson, Zongli Zheng, Matthew Liebers, Yoon Jin Cha, Quan Hoang Ho, Maristela Onozato, Long Phi Le, Rebecca S. Heist, A. John Iafrate, Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung. Journal of Thoracic Oncology. ,vol. 10, pp. 1156- 1162 ,(2015) , 10.1097/JTO.0000000000000579
S. Vatrano, L. Righi, T. Vavalá, I. Rapa, M. Busso, S. Izzo, S. Cappia, A. Veltri, M. Papotti, G. V. Scagliotti, S. Novello, Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study Targeted Oncology. ,vol. 11, pp. 157- 166 ,(2016) , 10.1007/S11523-015-0383-8
Hideaki Yamakawa, Noboru Takayanagi, Takashi Ishiguro, Naho Kagiyama, Yoshihiko Shimizu, Yutaka Sugita, A Favorable Response to Cisplatin, Pemetrexed and Bevacizumab in Two Cases of Invasive Mucinous Adenocarcinoma Formerly Known as Pneumonic-type Mucinous Bronchioloalveolar Carcinoma Internal Medicine. ,vol. 52, pp. 2781- 2784 ,(2013) , 10.2169/INTERNALMEDICINE.52.0766
Young K Kim, Dong H Shin, Kyung B Kim, Nari Shin, Won Y Park, Jung H Lee, Kyung U Choi, Jee Y Kim, Chang H Lee, Mee Y Sol, Mi H Kim, MUC5AC and MUC5B enhance the characterization of mucinous adenocarcinomas of the lung and predict poor prognosis Histopathology. ,vol. 67, pp. 520- 528 ,(2015) , 10.1111/HIS.12693
Greta Alì, Agnese Proietti, Serena Pelliccioni, Cristina Niccoli, Cristiana Lupi, Elisa Sensi, Riccardo Giannini, Nicla Borrelli, Maura Menghi, Antonio Chella, Alessandro Ribechini, Federico Cappuzzo, Franca Melfi, Marco Lucchi, Alfredo Mussi, Gabriella Fontanini, ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment. Archives of Pathology & Laboratory Medicine. ,vol. 138, pp. 1449- 1458 ,(2014) , 10.5858/ARPA.2013-0388-OA
A. Kumar, T. A. White, A. P. MacKenzie, N. Clegg, C. Lee, R. F. Dumpit, I. Coleman, S. B. Ng, S. J. Salipante, M. J. Rieder, D. A. Nickerson, E. Corey, P. H. Lange, C. Morrissey, R. L. Vessella, P. S. Nelson, J. Shendure, Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 17087- 17092 ,(2011) , 10.1073/PNAS.1108745108
Yasushi Yatabe, Takayuki Kosaka, Takashi Takahashi, Tetsuya Mitsudomi, EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. The American Journal of Surgical Pathology. ,vol. 29, pp. 633- 639 ,(2005) , 10.1097/01.PAS.0000157935.28066.35
Tímár József, None, The clinical relevance of KRAS gene mutation in non-small-cell lung cancer. Current Opinion in Oncology. ,vol. 26, pp. 138- 144 ,(2014) , 10.1097/CCO.0000000000000051
Kyuichi Kadota, Kei Suzuki, Stefan S Kachala, Emily C Zabor, Camelia S Sima, Andre L Moreira, Akihiko Yoshizawa, Gregory J Riely, Valerie W Rusch, Prasad S Adusumilli, William D Travis, A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma Modern Pathology. ,vol. 25, pp. 1117- 1127 ,(2012) , 10.1038/MODPATHOL.2012.58